Organon (LTS:0A9W) Total Stockholders Equity : $48 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Organon Total Stockholders Equity?

Organon's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $48 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Organon's Book Value per Share for the quarter that ended in Mar. 2024 was $0.19. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Organon's Debt-to-Equity for the quarter that ended in Mar. 2024 was 181.54.

Organon Total Stockholders Equity Historical Data

The historical data trend for Organon's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Total Stockholders Equity Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

7,035.00

5,486.00

-1,508.00

-892.00

-70.00

Organon Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial														-737.00	-555.00	-589.00	-70.00	48.00

Organon (LTS:0A9W) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Organon's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(48	-	0)	/	255.847
	=	0.19

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Organon's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9	+	8705)	/	48
	=	181.54

Organon Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Organon's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon (LTS:0A9W) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (LTS:0A9W) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

OGN:USA OGN:Mexico 1OGN:Italy 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.

Organon (LTS:0A9W) Headlines

No Headlines